Search for Hidden Infections Case Scenario Prof. Dr Seham Awad El Sherbini

Full Transcript — Download SRT & Markdown

00:00
Speaker A
عبد الرحمن 10 years old boy complaining of two painful erythematous skin nodules on his chest wall appeared one and a half year ago.
00:09
Speaker A
بس هي بقى لها سنه ونص يعني ظاهره
00:14
Speaker A
not associated with axillary swelling or any other swelling.
00:19
Speaker A
عملنا له biopsy من 6 شهور وطلع فيه scar
00:24
Speaker A
Another nodule appeared on lower abdomen. Condition wasn't associated with fever. Patient generally looks healthy, good built.
00:36
Speaker A
بس هو ده اللي احنا عملناه في الاول
00:38
Speaker A
Lower abdomen skin nodule changed to a black eschar on a red plaque then disappeared totally.
00:44
Speaker A
His back also showed macular rashes which disappeared spontaneously.
00:55
Speaker A
بعد كده عملنا له بقى ال investigations done according to the biopsy result.
00:57
Speaker A
The patient has already done tuberculin test which was negative and CT chest which was also normal at chest hospital.
01:04
Speaker A
then was referred to us. BCG scar not found.
01:49
Speaker A
طبعا انا يعني حولت اخش في ال diagnosis of lupus vulgaris
01:57
Speaker A
فحاولت اطبق عليه ال investigations بتاعته
02:11
Speaker A
Is it Lupus Vulgaris?
02:12
Speaker A
Lupus vulgaris is a chronic and progressive form of cutaneous tuberculosis that represents a reactivation of infection in people with moderate to high immunity against the bacillus.
02:18
Speaker A
It may occur either as a result of direct extension from an underlying focus or via lymphatic or hematogenous spread.
02:24
Speaker A
Without therapy, lesions of lupus vulgaris persist for years, and the plaques may grow to enormous sizes.
02:28
Speaker A
In addition, ulceration and destruction of underlying tissues may occur, causing severe disfigurement.
02:34
Speaker A
Lupus vulgaris usually begins as a collection of discrete, red-brown papules that subsequently coalesce to form an indolent, asymptomatic plaque.
02:40
Speaker A
The plaque gradually reaches a size of 0.5-10 cm and develops central clearing and atrophy.
02:45
Speaker A
The borders may acquire a serpiginous or verrucous quality. Hypertrophic, ulcerative and vegetative forms of lupus vulgaris may also occur.
02:52
Speaker A
In Western countries, lesions often develop on the head and neck.
02:56
Speaker A
In (sub)tropical areas, lesions are commonly found on the lower extremities or buttocks.
03:01
Speaker A
Is it Lupus Vulgaris?
03:03
Speaker A
Differential diagnosis of lupus vulgaris can be other forms of cutaneous TB, deep fungal infections, leishmaniasis, sarcoidosis.
03:09
Speaker A
hypertrophic lichen planus, lichen simplex chronicus, blastomycosis.
03:13
Speaker A
Lesions on the nose can mimic lepromatous leprosy, Wegener's granulomatosis and syphilis.
03:19
Speaker A
Investigations done through our clinic: Abdominal ultrasound and chest x-ray normal.
03:23
Speaker A
CT chest and abdomen with contrast normal. CT paranasal sinuses variable degree of pansinusitis.
03:29
Speaker A
CBC normal.
03:31
Speaker A
ESR 15 mm.
03:34
Speaker A
LDH 204 U/L (110-295).
03:38
Speaker A
ACE 99 U/L (8-52).
03:41
Speaker A
Total calcium 9.5 mg/dl.
03:44
Speaker A
Serum Quantiferon TB Gold negative.
03:47
Speaker A
Serum galactomannan 1 (positive >=0.5) which is quite sensitive.
03:52
Speaker A
Random blood sugar 78 mg/dl.
03:55
Speaker A
HbA1c 5.4.
03:57
Speaker A
HIV negative.
03:59
Speaker A
Dermatology consultation with senior staff and revision of slide pathology.
04:04
Speaker A
Rheumatology and immunology consultations.
04:07
Speaker A
Eye examination and slit lamp normal.
04:10
Speaker A
CT scans with contrast.
04:12
Speaker A
CT paranasal sinuses.
04:15
Speaker A
Chronological Lymphocytic count Follow up.
04:18
Speaker A
3/2022: 1140. ESR 37, 70. LDH 944.
04:22
Speaker A
7/2023: 1161. CD4 low? CD8 low?
04:26
Speaker A
1/2024: 2576. ESR 66, 115.
04:30
Speaker A
3/2024: 3402. ESR 15. LDH 204.
04:35
Speaker A
What causes transient lymphopenia and immunodysregulation?
04:40
Speaker A
Rare Case of Persistently Depressed T Lymphocyte Subsets After SARS-CoV-2 Infection.
04:44
Speaker A
Male, 82-year-old. Final Diagnosis: A rare case of persistently depressed T lymphocyte subsets post COVID-19 infection.
04:48
Speaker A
Symptoms: Shortness of breath. Medication: ---.
04:51
Speaker A
Clinical Procedure: ---. Specialty: Immunology + Infectious Diseases.
04:54
Speaker A
Objective: Unusual clinical course.
04:56
Speaker A
Background: On rare occasions, viral infections are known to also depress immune cell lines, further worsening clinical outcomes.
05:01
Speaker A
We describe a patient who presented 3 weeks after recovery from mild COVID-19 disease with clinical features of an atypical pneumonia.
05:06
Speaker A
and was found to have a low CD4+ T-cell count.
05:09
Speaker A
An 82-year-old man with a past medical history of coronary artery disease, rheumatoid arthritis, gout, hypertension, and atrial fibrillation.
05:16
Speaker A
presented with a 1-week history of progressively worsening shortness of breath and cough.
05:20
Speaker A
He was noted to have recovered from mild SARS-CoV-2 infection 3 weeks prior to his current presentation.
05:25
Speaker A
and had been at his baseline level of health following infection.
05:28
Speaker A
A T cell subset panel was obtained, which revealed an absolute CD3 count of 92.
05:34
Speaker A
(reference range 840-3060), absolute CD4 count of 52 (reference range 500-1400).
05:40
Speaker A
absolute CD8 count of 37 (reference range 180-1170), and a normal CD4:CD8 ratio.
05:45
Speaker A
He was subsequently started on atovaquone for pneumocystis jirovecii pneumonia prophylaxis.
05:49
Speaker A
Conclusion: This case highlights the need for a high index of suspicion for lymphocyte depletion in older patients with multiple comorbidities.
05:55
Speaker A
who present during or after SARS-CoV-2 infection with atypical symptoms that are suggestive of immunosuppression.
06:00
Speaker A
In such instances, there should be a low threshold to start prophylactic therapy for possible opportunistic infections.
06:06
Speaker A
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection.
06:11
Speaker A
A proportion of patients surviving acute coronavirus disease 2019 (COVID-19) infection develop post-acute COVID syndrome (long COVID (LC)).
06:18
Speaker A
lasting longer than 12 weeks. Here, we studied individuals with LC compared to age- and gender-matched recovered individuals without LC.
06:25
Speaker A
unexposed donors and individuals infected with other coronaviruses.
06:28
Speaker A
Patients with LC had highly activated innate immune cells, lacked naive T and B cells and showed elevated expression of type I IFN (IFN-β) and type III IFN (IFN-λ1) that remained persistently high at 8 months after infection.
06:38
Speaker A
Using a log-linear classification model, we defined an optimal set of analytes that had the strongest association with LC among the 28 analytes.
06:45
Speaker A
Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2.
06:50
Speaker A
Long COVID (LC) occurs after at least 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.
06:55
Speaker A
yet its etiology remains poorly understood. We used 'omic' assays and serology to deeply characterize the global and SARS-CoV-2-specific immunity.
07:02
Speaker A
in the blood of individuals with clear LC and non-LC clinical trajectories, 8 months postinfection.
07:06
Speaker A
We found that LC individuals exhibited systemic inflammation and immune dysregulation.
07:10
Speaker A
This was evidenced by global differences in T cell subset distribution implying ongoing immune responses.
07:14
Speaker A
as well as by sex-specific perturbations in cytolytic subsets.
07:17
Speaker A
LC individuals displayed increased frequencies of CD4+ T cells poised to migrate to inflamed tissues and exhausted SARS-CoV-2-specific CD8+ T cells.
07:24
Speaker A
higher levels of SARS-CoV-2 antibodies and a mis-coordination between their SARS-CoV-2-specific T and B cell responses.
07:29
Speaker A
Our analysis suggested an improper crosstalk between the cellular and humoral adaptive immunity in LC, which can lead to immune dysregulation.
07:35
Speaker A
inflammation and clinical symptoms associated with this debilitating condition.
07:40
Speaker A
Positive history of frequent playing in farms (soil).
07:43
Speaker A
Primary cutaneous Aspergillosis infection in immunocompetent host??
07:48
Speaker A
Lesions include single or multiple red or violet hardened plaques, nodules, or papules at the site of skin injury.
07:53
Speaker A
The lesions may be tender or symptom-free. As the lesions evolve, pus- or blood-filled blisters develop in the center.
07:59
Speaker A
which eventually become necrotic blacken ulcers or scabs. Lesions most commonly appear on the limbs and head.
08:05
Speaker A
and may affect a small or large area.
08:09
Speaker A
Table 1 Studies on Primary Cutaneous Aspergillosis Caused by Aspergillus fumigatus, in Order of Publication and First Author.
08:14
Speaker A
Mowat, 31 M/H, USA, Unknown, No, Arm, 1.2-cm hemorrhagic bulla, IV site, Amphotericin, 1 mo.
08:20
Speaker A
Camus, 37 F/M, France, Farmer, No, Cheek, eyebrow, palpebra superior, erythematous nodules, Oral ITZ 400 mg/d 15 d.
08:26
Speaker A
Sharma, 63 F/M, India, Farmer, No, Extremities, back, trunk, forehead, nodules plaques, Oral ITZ 200 mg/d 4 wk.
08:32
Speaker A
Klieger, 24 F/M, Finland, Welder, No, Back, purpuric necrotic papules, pustules evolving into crusts, Tattoo, Oral VCZ, local TER, 4wk.
08:39
Speaker A
surgical revision of necrotic tissue. Rocha, 50 F/M, India, Worker, No, Elbow, 4 x 4 cm cystic swelling, Trauma, Oral ITZ 200 mg/d 4 wk.
08:45
Speaker A
Liu, 9 M/H, China, Unemployed, No, Cheek, erythematous plaque covered with flava eschar, Trauma, Oral ITZ 75 mg/d, CPX ointment.
08:51
Speaker A
Rachana, 65 F/H, India, Farmer, MI, Left upper limb and trunk, swelling with pain, tightening of the skin, vesicles with watery discharge, Trauma, ITZ, 2 mo.
08:58
Speaker A
Mada, 80 M/H, USA, Farmer, BCC, Right ear, erythematous swelling, Surgery, Oral VCZ 200mg/12h, 4wk, incision and drainage.
09:05
Speaker A
Fan, 68 F/M, China, Unknown, Gout, HTN, Back of hand, erythematous erythema with ulceration and exudation, IV VCZ 200 mg q12h, 25 d.
09:13
Speaker A
Primary Cutaneous Aspergillosis Due to Aspergillus fumigatus in an Immunocompetent Patient with Diabetes Mellitus After Tattooing: A Case Report and Review of Literature.
09:20
Speaker A
A 46-year-old woman presented with erythematous papules, papulopustules, and a plaque on the right lower limb of more than two years duration without other symptoms.

Get More with the Söz AI App

Transcribe recordings, audio files, and YouTube videos — with AI summaries, speaker detection, and unlimited transcriptions.

Or transcribe another YouTube video here →